¼¼°èÀÇ ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå º¸°í¼­(2025³â)
Continuous Glucose Monitoring Devices Global Market Report 2025
»óǰÄÚµå : 1716935
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,319,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,134,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,949,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2029³â¿¡´Â CAGR 16.96%·Î 184¾ï 5,000¸¸ ´Þ·¯·Î ¼ºÀåÇÕ´Ï´Ù. ¿¹Ãø ±â°£ Áß ¿¹»óµÇ´Â ¼ºÀåÀº ÀÇ·áºñ ÁöÃâ Áõ°¡, ´ç´¢º´ °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ´ç´¢º´ ȯÀÚ ¼ö Áõ°¡, ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ÀåºñÀÇ Àαâ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ Áß ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, CGM ½Ã½ºÅÛ Çõ½Å, ÀμöÇÕº´, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, Á¦ÈÞ ¹× Çù·Â µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

´ç´¢º´ À¯º´·ü Áõ°¡´Â ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ç´¢º´Àº Àν¶¸° ºÐºñ ºÎÁ· ¶Ç´Â Àν¶¸° ÀúÇ×¼ºÀ¸·Î ÀÎÇØ ½Åü°¡ Ç÷´çÀ» ÀûÀýÈ÷ Á¶ÀýÇÏÁö ¸øÇÏ´Â ÁúȯÀÔ´Ï´Ù. ´ç´¢º´ Áõ°¡ÀÇ ÁÖ¿ä ¿øÀÎÀº ½Ä½À°ü Àå¾Ö, ÁÂ½Ä »ýȰ½À°ü, ºñ¸¸, °í·ÉÈ­, À¯ÀüÀû ¼ÒÀÎ µîÀÔ´Ï´Ù. ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) Àåºñ´Â Ç÷´ç ¼öÄ¡¿¡ ´ëÇÑ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÔÀ¸·Î½á ´ç´¢º´ °ü¸®¸¦ µ½°í, Àû½Ã¿¡ Ä¡·á Á¶Á¤ ¹× »ýȰ½À°ü º¯È­¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 3¿ù ¿µ±¹ Á¤ºÎ ºÎ¼­ÀÎ Office for Health Improvement &Disparities´Â 2022³â 3¿ù°ú 2023³â 3¿ù »çÀÌ¿¡ ±ÇÀåµÇ´Â 8°¡Áö Ä¡·á °úÁ¤À» ¸ðµÎ ¹ÞÀº 1Çü ´ç´¢º´ ȯÀÚÀÇ ºñÀ²ÀÌ 22% Áõ°¡Çß°í, 2Çü ´ç´¢º´Àº 21% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. 21% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ¶ÇÇÑ HbA1c ¸ñǥġ¸¦ ´Þ¼ºÇÑ È¯ÀÚÀÇ ºñÀ²Àº 37.9%·Î Àü±¹ ´ç´¢º´ °¨»ç(NDA)¿¡¼­ ¿ª´ë ÃÖ°íÄ¡¸¦ ±â·ÏÇß½À´Ï´Ù. ±× °á°ú, ´ç´¢º´ À¯º´·ü Áõ°¡´Â ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº °³ÀÎÀÇ Ç÷´ç °ü¸® Á¢±Ù¼º, Á¤È®¼º, »ç¿ë¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ½ÃÆÇµÇ´Â Áö¼ÓÀû Ç÷´ç ¸ð´ÏÅÍ¿Í °°Àº Çõ½ÅÀûÀÎ ±â¼ú °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ½ÃÆÇ ÁßÀÎ CGM Àåºñ´Â »ç¿ëÀÚ°¡ ó¹æÀü ¾øÀ̵µ Áö¼ÓÀûÀ¸·Î Ç÷´ç ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 9¿ù ¹Ì±¹ ÀÇ·á±â±â ȸ»çÀÎ Abbott Laboratories´Â Lingo ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Àåºñ´Â »ç¿ëÀÚ¿¡°Ô ½Ç½Ã°£ Æ÷µµ´ç µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© ÇÏ·ç Á¾ÀÏ Ç÷´ç¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí Áï°¢ÀûÀÎ Çǵå¹éÀ» Á¦°øÇÕ´Ï´Ù. º¸±â ½¬¿î µð½ºÇ÷¹À̸¦ °®Ãá ¼¼·ÃµÈ µðÀÚÀÎÀÌ Æ¯Â¡À̸ç, ¸ð¹ÙÀÏ ¾Û°ú ÅëÇÕÇÏ¿© Ãß¼¼¸¦ ÃßÀûÇÏ°í °æ°í¸¦ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½ºÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Continuous glucose monitoring (CGM) devices are used to track blood sugar levels in real time by placing a sensor under the skin. These devices offer continuous data, trend insights, and alerts for both high and low blood sugar levels, which helps manage diabetes more effectively. CGM devices reduce the need for frequent finger pricks and improve glucose control.

The primary components of continuous glucose monitoring devices include transmitters, sensors, and receivers. Transmitters are the components that transmit glucose level data from the sensor to the receiver or connected device for monitoring. They typically connect via Bluetooth or 4G technology. CGM devices are used across various demographics, including both children and adults, for managing conditions such as gestational diabetes, type-1 diabetes, and type-2 diabetes. These devices are utilized in a range of settings, including hospitals, homecare environments, and other healthcare settings.

The continuous glucose monitoring devices market research report is one of a series of new reports from The Business Research Company that provides continuous glucose monitoring devices market statistics, including the continuous glucose monitoring devices industry global market size, regional shares, competitors with the continuous glucose monitoring devices market share, detailed continuous glucose monitoring devices market segments, market trends, and opportunities, and any further data you may need to thrive in the continuous glucose monitoring devices industry. This continuous glucose monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The continuous glucose monitoring devices market size has grown rapidly in recent years. It will grow from $8.41 billion in 2024 to $9.86 billion in 2025 at a compound annual growth rate (CAGR) of 17.22%. The growth during the historic period can be attributed to factors such as enhanced patient safety and improved health outcomes, a growing demand for diabetes management devices, greater usage of CGM devices, an increase in diabetes cases, and rising patient trust in these devices.

The continuous glucose monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.45 billion in 2029 at a compound annual growth rate (CAGR) of 16.96%. The anticipated growth in the forecast period is driven by factors such as increased healthcare spending, heightened awareness about diabetes management, a rise in the number of diabetes cases, and the growing popularity of continuous glucose monitoring devices. Key trends in the forecast period include advancements in technology, innovations in CGM systems, mergers and acquisitions, regulatory approvals, and partnerships and collaborations.

The growing prevalence of diabetes is expected to drive the expansion of the continuous glucose monitoring devices market. Diabetes is a condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or insulin resistance. The increasing rates of diabetes are primarily attributed to factors such as poor diets, sedentary lifestyles, obesity, aging populations, and genetic predispositions. Continuous glucose monitoring (CGM) devices aid in managing diabetes by providing real-time data on blood glucose levels, enabling timely treatment adjustments and lifestyle changes. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the percentage of patients achieving target HbA1c levels reached 37.9%, the highest ever recorded in the National Diabetes Audit (NDA). As a result, the rising prevalence of diabetes is significantly contributing to the growth of the continuous glucose monitoring devices market.

Leading companies in the continuous glucose monitoring devices market are focused on developing innovative technologies, such as over-the-counter continuous glucose monitors, to improve accessibility, accuracy, and usability for individuals managing blood glucose levels. An over-the-counter CGM device allows users to continuously monitor their blood glucose levels without the need for a prescription. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched the Lingo continuous glucose monitoring system. This device provides users with real-time glucose data, offering continuous monitoring and instant feedback on blood sugar levels throughout the day. It features a sleek design with easy-to-read displays and integrates with mobile apps for tracking trends and receiving alerts.

In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition allows Abbott to enhance its diabetes care offerings by combining Bigfoot Biomedical's smart insulin management systems with its Freestyle Libre technology. Bigfoot Biomedical, a US-based medical technology company, specializes in solutions that integrate with continuous glucose monitoring (CGM) devices.

Major players in the continuous glucose monitoring devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., Nemaura Medical Inc.

North America was the largest region in the continuous glucose monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in continuous glucose monitoring devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous glucose monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous glucose monitoring (CGM) devices include revenues earned by entities by providing services such as real-time glucose monitoring, data sharing, trend analysis, and high or low alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring (CGM) devices market also consists of sales of products including dexcom, freestyle libre, medtronic, and eversense. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Glucose Monitoring Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous glucose monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for continuous glucose monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous glucose monitoring devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Continuous Glucose Monitoring Devices Market Characteristics

3. Continuous Glucose Monitoring Devices Market Trends And Strategies

4. Continuous Glucose Monitoring Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Continuous Glucose Monitoring Devices Growth Analysis And Strategic Analysis Framework

6. Continuous Glucose Monitoring Devices Market Segmentation

7. Continuous Glucose Monitoring Devices Market Regional And Country Analysis

8. Asia-Pacific Continuous Glucose Monitoring Devices Market

9. China Continuous Glucose Monitoring Devices Market

10. India Continuous Glucose Monitoring Devices Market

11. Japan Continuous Glucose Monitoring Devices Market

12. Australia Continuous Glucose Monitoring Devices Market

13. Indonesia Continuous Glucose Monitoring Devices Market

14. South Korea Continuous Glucose Monitoring Devices Market

15. Western Europe Continuous Glucose Monitoring Devices Market

16. UK Continuous Glucose Monitoring Devices Market

17. Germany Continuous Glucose Monitoring Devices Market

18. France Continuous Glucose Monitoring Devices Market

19. Italy Continuous Glucose Monitoring Devices Market

20. Spain Continuous Glucose Monitoring Devices Market

21. Eastern Europe Continuous Glucose Monitoring Devices Market

22. Russia Continuous Glucose Monitoring Devices Market

23. North America Continuous Glucose Monitoring Devices Market

24. USA Continuous Glucose Monitoring Devices Market

25. Canada Continuous Glucose Monitoring Devices Market

26. South America Continuous Glucose Monitoring Devices Market

27. Brazil Continuous Glucose Monitoring Devices Market

28. Middle East Continuous Glucose Monitoring Devices Market

29. Africa Continuous Glucose Monitoring Devices Market

30. Continuous Glucose Monitoring Devices Market Competitive Landscape And Company Profiles

31. Continuous Glucose Monitoring Devices Market Other Major And Innovative Companies

32. Global Continuous Glucose Monitoring Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Glucose Monitoring Devices Market

34. Recent Developments In The Continuous Glucose Monitoring Devices Market

35. Continuous Glucose Monitoring Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â